MRVI icon

Maravai LifeSciences
MRVI

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$5
48% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Conor McNamara
50% 1-yr MRVI win rate
12 Aug ‘25 2 months ago
Craig-Hallum
Craig-Hallum
Christian Schwab
50% 1-yr MRVI win rate
12 Aug ‘25 2 months ago